Fillerworld Logo Search
NEXT day delivery available - 3pm cut off NEXT day delivery available - 3pm cut off
Worldwide shipping available Worldwide shipping available
Free standard UK delivery on orders over £100 Free standard UK delivery on orders over £100

What AMI Eyes Contains and How to Use It Around the Eye

This article is written for qualified aesthetic practitioners and prescribers. It is technical information, not advice for members of the public.

AMI Eyes is a Korean polynucleotide (PN) skin booster supplied in a 2ml pre-filled syringe and marketed for needle mesotherapy of the periorbital area and tear trough. It is a tissue-quality product rather than a volumiser: it does not replace the volume a tear trough filler restores, and it is usually given as a short course of superficial intradermal treatments. If you are deciding whether to add it to your menu, the practical questions are what is actually in the syringe, which patients it suits, how to place it, and what paperwork to check before you buy. This piece works through each in turn.

What AMI Eyes contains

The active ingredient is purified polynucleotide, the long-chain DNA fraction derived from salmon. Our AMI Eyes 2ml product listing gives the concentration as 10mg/ml, which works out at 20mg of PN per syringe. Third-party product directories name the manufacturer as Quiver Medic, South Korea.

You will see "PN" and "PDRN" used interchangeably in distributor copy for this product. They are not quite the same thing. PDRN (polydeoxyribonucleotide) usually refers to shorter, lower molecular weight fragments, while PN describes longer chains that form a more viscous gel. For AMI Eyes, the figure printed on the pack and insert is the one to trust, so check the batch you receive rather than relying on a website summary.

The formulation contains no cross-linked hyaluronic acid, which matters for two reasons. First, it should not be expected to lift or fill a hollow. Second, hyaluronidase is not a reversal agent for it, so your complication plan for this product looks different from your plan for HA filler in the same area.

How AMI Eyes compares with Lumi Eyes

Practitioners often weigh AMI Eyes against Dermaren Lumi Eyes, which is sold for the same indication. The main differences you will notice at the bench are format and formulation. AMI Eyes comes as a single 2ml syringe, while Lumi Eyes is a 1ml syringe, and the Lumi Eyes listing describes a PN base with added glutathione. Both are positioned for a course of treatments rather than a single session. Neither is a better choice in every case. The decision usually comes down to the volume you want per session, your handling preference and what your supplier can document.

Patient selection for the periorbital area

PN boosters around the eye sit best with patients whose main concern is skin quality: thin, crepey lower-lid skin, fine static lines and a dull, tired look where the bony anatomy and fat pads are broadly intact. They make less sense as the only treatment for a deep tear trough with a marked bony deficit, prominent fat-pad herniation or significant festoons. Those patients may need a different plan or a surgical referral.

A focused assessment should cover:

  • Skin thickness and laxity – pinch and snap tests on the lower lid give a quick sense of how much support the tissue has.
  • Type of dark circle – pigmented, vascular and structural shadowing respond differently, and patients rarely know which they have.
  • Oedema history – patients with morning puffiness or malar oedema need a frank discussion about swelling after injection.
  • Previous treatments – note any existing filler in the tear trough, recent laser or peels, and blepharoplasty history.

Contraindications to screen for

Because the active ingredient comes from salmon, a fish or salmon allergy is the first thing to rule out. Beyond that, the usual mesotherapy exclusions apply: active infection or herpes near the treatment site, inflammatory skin disease in the area, pregnancy and breastfeeding (safety has not been established), and caution with anticoagulants or bleeding disorders. Record the screening in the notes and take written consent that covers bruising, swelling, lumps and the possibility of a limited response.

Technique: depth, needles and volume

AMI Eyes is designed for needle mesotherapy. Most practitioners work with a fine 30G or 32G needle and place small aliquots into the superficial dermis using a microdroplet or micropapule technique. Some distributors also describe cannula use. Either way, the aim is even, superficial placement across the treatment zone rather than a bolus in one spot.

Practical points that make a difference in the lower lid:

  • Stay superficial and stay on bone laterally. Keep to the area of skin you assessed, respect the orbital rim and keep well away from the lash line.
  • Use small aliquots. PN gels are viscous, and over-sized papules in thin lid skin can linger and look irregular.
  • Change needles often. Fine needles blunt quickly after repeated passes, which increases trauma and bruising. Our needles range covers the fine gauges used for this work.
  • Plan the syringe. A 2ml syringe is more than many practitioners need for both lower lids in one session. Decide in advance whether the remainder is used on adjacent areas listed on the insert or discarded. Never store an opened syringe for another patient.

Expect visible papules for a few hours and some swelling for a day or two, especially in patients prone to oedema. Small bruises are common in this area. Tell patients this before you start, so a normal reaction is not mistaken for a complication.

Building a treatment course

PN products are generally given as a course. Commonly described protocols use three sessions spaced two to four weeks apart, followed by maintenance at intervals agreed with the patient. Follow the manufacturer's insert for the batch you are using, as instructions can differ between distributors and packaging versions.

On evidence, set expectations honestly. A 2026 prospective observational study of 42 patients in the Journal of Cosmetic Dermatology (Ziade et al.) reported that intradermal polynucleotide injections for periorbital lines were associated with improvements in appearance and patient satisfaction, with minimal adverse events. The authors describe their uncontrolled design as exploratory and say controlled trials are needed. That study did not test AMI Eyes specifically, so treat brand-level marketing claims with the same caution.

Standardised photographs at baseline and at each visit, taken in the same lighting and position, are the most useful tool you have for reviewing progress with the patient.

Sourcing, regulation and storage

The regulatory status of PN boosters is not always clear from supplier websites. Before you add AMI Eyes, or any PN product, to your stock, ask your supplier for the documents that support it being placed on the Great Britain market. That means the CE or UKCA marking information, the declaration of conformity and the instructions for use. The MHRA explains the current rules in its guidance on regulating medical devices in the UK. Your insurer may also ask which products you use, so keep those documents on file.

For storage, follow the temperature range on the outer carton, keep syringes in their sealed packaging until use and do not freeze them. Record batch numbers and expiry dates in the treatment notes so you can trace any product-related query.

If you are comparing options, our polynucleotides and PDRN collection brings together the PN products we stock for face and eye work.

Frequently asked questions

How many sessions of AMI Eyes are usually given?

A course of three sessions, two to four weeks apart, is the protocol most often described, followed by maintenance. Always check the insert supplied with your batch, and adjust to the patient's tissue response and tolerance of swelling.

Is AMI Eyes a filler?

No. It contains polynucleotide without cross-linked hyaluronic acid, so it is used to support skin quality rather than replace lost volume. Patients with a structural tear trough deficit may need a different approach.

What are the common side effects?

Visible papules straight after treatment, temporary swelling and bruising are the reactions practitioners see most often around the eye. Hypersensitivity is possible, particularly in patients with a fish allergy, which is why screening matters.

Can AMI Eyes be dissolved with hyaluronidase?

Hyaluronidase acts on hyaluronic acid, and AMI Eyes is a polynucleotide product, so it should not be considered a reversal agent. Superficial placement and conservative volumes are your main safeguards.

What is the difference between AMI Eyes and Lumi Eyes?

Both are PN-based boosters for the periorbital area. AMI Eyes is supplied as a 2ml syringe at 10mg/ml PN, while Lumi Eyes is a 1ml syringe whose listing also mentions glutathione. Choose based on session volume, handling and supplier documentation.

The bottom line

AMI Eyes is a practical option when the problem is lower-lid skin quality rather than volume loss. It works best inside a clear plan: careful selection, fish-allergy screening, superficial placement with fine needles, a defined course and honest expectations. Check the regulatory paperwork before you buy, record batch details every time, and keep filler and surgical referral in reserve for the patients a booster cannot help.

Stay in the Glow!

Subscribe for Exclusive Deals & the Latest Aesthetic Trends

Basket
Orders placed before 3PM will be dispatched the same day. Products For Professional Use Only.